Shares jump for potential targets of Sanofi deal
NJ governor offers tax cap compromiseTRENTON, N.J. — New Jersey Gov. Chris Christie offered an alternative to the competing plans he and Democrats proposed to slow rising property taxes, while threatening to keep the Legislature in Trenton through the holiday weekend to deal with taxpayers' No. 1 issue.
Federal judge rules for Merck in state Vioxx suit
NJ's Lautenberg, now oldest senator: Cancer gone
US Sen. Lautenberg of NJ says he's cancer-free
More News
- Latest failure of experimental Pfizer drug in late testing shows worrisome trend, hurts stock
- J&J licenses late-stage Type 2 diabetes drug from Diamyd; gets preclincal drugs from Metabolex
- NJ Gov.’s property tax cap plan stalled as Dems offer less rigid alternatives
- Cash-strapped NJ Sports Authority spends $1M on season tickets, $200K to keep contracts secret
- NJ governor, business leaders launch business-attracting venture
- Amtrak counterterrorism drill boosts security at rail stations from New Hampshire to Virginia
- Shareholders of drugmaker Merck ask CEO about propspects for higher dividend, stock price
- 30,000 to 35,000 NJ protesters rally against state budget cuts proposed by Gov. Chris Christie
- Tens of thousands of protesters rally against NJ budget cuts proposed by Gov. Chris Christie
- Campbell Soup Co. to report Q3 earnings, covering end of soup season
- Governor wants New Jersey towns to decide how much affordable housing they should build
- Three drugmakers post improved 1st-quarter profits and sales, rest of year looks less rosy
- Bristol-Myers sees big jumps in Q1 sales, profit, but lowers forecast on health overhaul costs
- Bristol-Myers sees big jumps in 1Q sales, profit, but lowers forecast on health overhaul costs
- Drugmaker Merck promotes key VP to president, prelude to CEO’s retirement next year
- Drugmaker Merck buys rights to help promote potential Nycomed drug for chronic lung condition
- Merck: Health care overhaul to cost drugmaker roughly $320M in 2010 rebates, lost tax benefit
- Merck: Health care overhaul to cost drugmaker $320M this year in rebates, lost tax benefit
- Merck, expanding vaccine line, reaches deal for US distribution of tetanus, diphtheria shot
- Device, drugmaker J&J needs revenue to rebound; investors also watching health reform impact
- Merck CEO Clark got $11.9 million in 2009 compensation, down sharply despite major acquisition
- JetBlue flight returns to NJ airport after engine cover falls off plane; no injuries reported
- Pfizer posts data showing it gave docs $35M for consulting, drug studies in last half of 2009
- NY Daily News wins 2 top National Headliner Awards; broadcasters in DC, Indy also honored
- Britain’s AstraZeneca wins first trial in case alleging psychiatric drug Seroquel caused harm
- Johnson & Johnson CEO gets 11 pct 2009 raise, to $25.6M, despite layoffs, rare drop in revenue
- Analyst: Sales of Merck cholesterol pill Vytorin will keep falling, no matter what study finds
- 2009 compensation for Bristol-Myers Squibb CEO Cornelius falls 22 percent amid recession
- Merck, Frontline maker Sanofi-Aventis uniting animal medicine businesses into world’s largest
- Pfizer CEO Kindler got 2009 compensation worth $13.7M, down 8 percent, due to weak economy
- NJ Transit to boost fares by 25 percent, cut service to help address growing budget woes
- Bristol-Myers: 60 drugs in testing, other efforts will help overcome 2012 loss of Plavix sales
- Bristol-Myers expects profit of at least $1.95 a share in 2013, first full year without Plavix
- Pfizer says Alzheimer’s treatment Dimebon did not meet any goals in 1st late stage trial
- Bristol-Myers’ Cornelius to retire as CEO, but still head board; COO Andreotti to succeed him
- Post Schering-Plough purchase, drugmaker Merck has 43 compounds in late tests, 4 under review
- Merck: Last Vioxx payouts coming soon from $4.85B fund to settle heart attack, stroke lawsuits
- Post Schering-Plough purchase, drugmaker Merck has 40 compounds in late tests, 4 under review
- Experts: Obama insurance rate plan may have small effect, except in states with no rules
- Nets reach deal to play at Newark arena until new Brooklyn home is built
- Johnson & Johnson changing its bonus program to increase uniformity, reward performance more
- Merck: Studies show Gardasil vaccine protects older women, gay men from genital cancers, warts
- Merck sales and profit up sharply in 4th quarter due to $41.1B Schering-Plough purchase
- Health insurance rates up sharply in several states for those who don’t get employer coverage
- Audit finds NJ property tax rebate and deduction programs pay people who don’t qualify
- Merck to report on Schering-Plough integration, new biotech ventures, drugs in development
- Merck to appoint drug safety panels, chief medical officer to end shareholder Vioxx lawsuits
- NJ Gov, lawmakers to review sports, gaming, entertainment authorities, facilities
- NJ Gov. Christie orders review of Garden State sports, gaming and entertainment authorities
- Pfizer posts big jump in 4th-qtr sales, profit thanks to $68 billion Wyeth acquisition
- Drugmakers report 4Q sales up around 10 percent, but profits and outlooks are a mixed bag
- Bristol-Myers 4th-qtr profit rises on higher sales of key drugs, gain from Mead Johnson sale
- Bristol-Myers’ profit way up on higher sales of nearly all drugs, gain from Mead Johnson sale
- Drugmaker Pfizer to focus on 6 research priorities, dump 100 compounds, as it integrates Wyeth
- Bristol-Myers Squibb, after nutrition business sale, has new pure pharma focus, $8B for deals
- Johnson & Johnson 4th-qtr sales climb 9 pct, but profit falls on $1.1B restructuring charge
- Amid major layoffs, Tylenol recall, Johnson & Johnson hopes news drugs, devices get approval
- NJ gov signs orders to toughen pay-to-play, keep casinos open, temporarily freeze mandates
- NJ’s new governor begins tenure, says he has inherited a $1.2 billion budget gap
- New Jersey’s unemployment rate climbs to 33-year high of 10.1 percent in December
- NJ’s new governor, Republican Chris Christie, says ‘change has arrived’
- New Republican governor takes office in New Jersey, reminder of party’s November wins
- Republican Chris Christie takes oath as NJ’s 55th governor
- Drug makers, insurers, suppliers donate $15.5M in cash, medicine, products for Haiti relief
- New Jersey tax collections for December beat target for 2nd straight month
- J&J, foundation to start testing of artificial pancreas in insulin-dependent diabetics
- Bill adopted by NJ lawmakers would make let state officials get jobs representing casinos
- GOP, Gov.-elect Christie cry foul over aid to select NJ cities in Democratic gov’s last days
- Report: NJ doing better at protecting kids since cases of extreme abuse threw state into court
- New Jersey lawmaker seeks to bar nongovernment workers from enrolling in state pension system
- George Washington gets $400,000 from Lockheed Martin to keep crossing the Delaware River
- NJ governor trims budget, and governor-elect Christie prepares for sweeping cuts to come
- Budget cuts mean paying customer will ride with George Washington in annual river crossing
- Sanofi-Aventis to buy health-care company Chattem for $1.9 billion, entree into US OTC market
- Sanofi-Aventis agrees to buy US healthcare company Chattem for $1.9 billion
- Merck expands push into biotech drugs with purchase of Avecia, British contract manufacturer
- New Jersey’s jobless rate holds steady at 9.7 percent in November; October job figures revised
- Decision delayed on NJ proposal to require cooling towers at Oyster Creek nuclear plant
- New Jersey lawmakers to consider ‘Do-Not-Solicit’ registry to block solicitations
- New Jersey Senate passes bill to restrict electronic cigarettes like the real thing
- New Jersey Senate approves bill to require restaurant chains to post calorie counts
- Christie says $1.2B transportation bond sale was to ‘pay bills,’ doesn’t count as new spending
- NJ Transit awards $583 million contract to NJ, NY companies for trans-Hudson tunnel project
- Towns may sue New Jersey gov’t to recover $21 million in frozen property tax relief payments
- Investigation finds lucrative perks for some on local government payrolls in New Jersey
- Pfizer, Protalix ink deal on technology to make drugs in plant cells, initially for Gaucher’s
- New Jersey voters may vote next year on constitutional amendment to ban fund raids
- Fighting swine flu, companies dole out hygiene tips, hand sanitizer to keep operations healthy
- New Jersey leaders grapple with growing budget deficit; additional spending cuts coming
- Survey finds NJ businesses pessimistic over economic turnaround in 2010
- New Jersey Senate committee OKs bill to require restaurant chains to post calorie counts
- Britain’s GlaxoSmithKline pulls application to sell enlarged prostate drug for blocking cancer
- Christie’s budget group says NJ finances worse than believed; making requests of Corzine
- NJ man accused of stealing Web domain name, selling it to former NBA player for $111,000
- Wild turkey on NJ Turnpike evades capture after causing havoc for toll collectors, motorists
